Your browser doesn't support javascript.
Gene amplification acts as a molecular foothold to facilitate cross-species adaptation and evasion of multiple antiviral pathways.
Banerjee, Shefali; Smith, Cathy; Geballe, Adam P; Rothenburg, Stefan; Kitzman, Jacob O; Brennan, Greg.
  • Banerjee S; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA 95616, USA.
  • Smith C; Departments of Microbiology and Medicine, University of Washington, Seattle, WA 98195, USA.
  • Geballe AP; Departments of Human Genetics and Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
  • Rothenburg S; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Kitzman JO; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA 95616, USA.
  • Brennan G; Departments of Microbiology and Medicine, University of Washington, Seattle, WA 98195, USA.
Virus Evol ; 8(2): veac105, 2022.
Article in English | MEDLINE | ID: covidwho-2161170
ABSTRACT
Cross-species spillover events are responsible for many of the pandemics in human history including COVID-19; however, the evolutionary mechanisms that enable these events are poorly understood. We have previously modeled this process using a chimeric vaccinia virus expressing the rhesus cytomegalovirus-derived protein kinase R (PKR) antagonist RhTRS1 in place of its native PKR antagonists E3L and K3L (VACVΔEΔK + RhTRS1). Using this virus, we demonstrated that gene amplification of rhtrs1 occurred early during experimental evolution and was sufficient to fully rescue virus replication in partially resistant African green monkey (AGM) fibroblasts. Notably, this rapid gene amplification also allowed limited virus replication in otherwise completely non-permissive human fibroblasts, suggesting that gene amplification may act as a 'molecular foothold' to facilitate viral adaptation to multiple species. In this study, we demonstrate that there are multiple barriers to VACVΔEΔK + RhTRS1 replication in human cells, mediated by both PKR and ribonuclease L (RNase L). We experimentally evolved three AGM-adapted virus populations in human fibroblasts. Each population adapted to human cells bimodally, via an initial 10-fold increase in replication after only two passages followed by a second 10-fold increase in replication by passage 9. Using our Illumina-based pipeline, we found that some single nucleotide polymorphisms (SNPs) which had evolved during the prior AGM adaptation were rapidly lost, while thirteen single-base substitutions and short indels increased over time, including two SNPs unique to human foreskin fibroblast (HFF)-adapted populations. Many of these changes were associated with components of the viral RNA polymerase, although no variant was shared between all three populations. Taken together, our results demonstrate that rhtrs1 amplification was sufficient to increase viral tropism after passage in an 'intermediate species' and subsequently enabled the virus to adopt different, species-specific adaptive mechanisms to overcome distinct barriers to viral replication in AGM and human cells.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: Virus Evol Year: 2022 Document Type: Article Affiliation country: Ve

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: Virus Evol Year: 2022 Document Type: Article Affiliation country: Ve